牛牛AI助手已提取核心信息
On February 6, 2024, a Schedule 13G filing was made with the United States Securities and Exchange Commission by Lind Global Fund II LP, Lind Global Partners II LLC, and Jeff Easton, collectively referred to as the Reporting Persons, indicating a significant ownership stake in Cingulate Inc. The filing, which is a requirement under the Securities Exchange Act of 1934 for certain ownership thresholds, reveals that the Reporting Persons collectively own 282,000 shares of Cingulate Inc.'s common stock, representing 9.9% of the company's class of securities. This ownership includes 282,000 shares of common stock and various warrants, although the exercise of these warrants is limited to prevent ownership exceeding the reported amount. The Reporting Persons have sole voting and dispositive power over these shares. The principal business office for the Reporting Persons is located at 444 Madison Ave, Floor 41, New York, NY 10022. The filing asserts that the shares were not acquired for the purpose of changing or influencing the control of Cingulate Inc. and were not held in connection with any transaction having that purpose or effect.
On February 6, 2024, a Schedule 13G filing was made with the United States Securities and Exchange Commission by Lind Global Fund II LP, Lind Global Partners II LLC, and Jeff Easton, collectively referred to as the Reporting Persons, indicating a significant ownership stake in Cingulate Inc. The filing, which is a requirement under the Securities Exchange Act of 1934 for certain ownership thresholds, reveals that the Reporting Persons collectively own 282,000 shares of Cingulate Inc.'s common stock, representing 9.9% of the company's class of securities. This ownership includes 282,000 shares of common stock and various warrants, although the exercise of these warrants is limited to prevent ownership exceeding the reported amount. The Reporting Persons have sole voting and dispositive power over these shares. The principal business office for the Reporting Persons is located at 444 Madison Ave, Floor 41, New York, NY 10022. The filing asserts that the shares were not acquired for the purpose of changing or influencing the control of Cingulate Inc. and were not held in connection with any transaction having that purpose or effect.
2024年2月6日，Lind Global Fund II LLP、Lind Global Partners II LLC和Jeff Easton（统称为 “申报人”）向美国证券交易委员会提交了附表13G申报，表明申报人共拥有28.2万股Cingulate Inc的重大所有权，这是1934年《证券交易法》对某些所有权门槛的要求。Inc.'s 普通股，占公司证券类别的9.9％。该所有权包括28.2万股普通股和各种认股权证，尽管这些认股权证的行使仅限于防止所有权超过申报金额。申报人对这些股票拥有唯一的投票权和处置权。举报人的主要业务办公室位于纽约麦迪逊大道444号41楼，纽约10022。该文件称，收购这些股份不是为了改变或影响Cingulate Inc.的控制权，也不是与任何具有该目的或效果的交易有关而持有的。
2024年2月6日，Lind Global Fund II LLP、Lind Global Partners II LLC和Jeff Easton（统称为 “申报人”）向美国证券交易委员会提交了附表13G申报，表明申报人共拥有28.2万股Cingulate Inc的重大所有权，这是1934年《证券交易法》对某些所有权门槛的要求。Inc.'s 普通股，占公司证券类别的9.9％。该所有权包括28.2万股普通股和各种认股权证，尽管这些认股权证的行使仅限于防止所有权超过申报金额。申报人对这些股票拥有唯一的投票权和处置权。举报人的主要业务办公室位于纽约麦迪逊大道444号41楼，纽约10022。该文件称，收购这些股份不是为了改变或影响Cingulate Inc.的控制权，也不是与任何具有该目的或效果的交易有关而持有的。
有用
没用